13.10

5.48% 0.68

Oric Pharmaceuticals Inc (ORIC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$12.42

Aprire:

$12.58

Volume 24 ore:

1.46M

Relative Volume:

1.09

Capitalizzazione di mercato:

$1.27B

Reddito:

Utile/perdita netta:

$-137.25M

Rapporto P/E:

-6.9312

EPS:

-1.89

Flusso di cassa netto:

$-121.97M

1 W Prestazione:

+2.50%

1M Prestazione:

+25.24%

6M Prestazione:

+152.41%

1 anno Prestazione:

+55.21%

Intervallo 1D:

$12.47

$13.38

Intervallo di 1 settimana:

$11.71

$13.38

Portata 52W:

$3.8951

$14.93

Oric Pharmaceuticals Inc Stock (ORIC) Company Profile

Nome

Oric Pharmaceuticals Inc

Settore

Healthcare (1140)

Industria

Biotechnology (637)

Telefono

(650) 388-5600

Indirizzo

240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA

Dipendente

128

Cinguettio

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

ORIC's Discussions on Twitter

Confronta ORIC con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ORIC Oric Pharmaceuticals Inc	13.10	1.21B	0	-137.25M	-121.97M	-1.89
VRTX Vertex Pharmaceuticals Inc	421.39	108.36B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	463.43	60.82B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	577.95	61.02B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	817.32	50.01B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	310.81	34.05B	4.56B	-176.77M	225.30M	-1.7177

Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-09-04	Ripresa	Guggenheim	Buy
2025-07-08	Iniziato	Ladenburg Thalmann	Buy
2024-10-31	Iniziato	Wells Fargo	Overweight
2024-09-06	Iniziato	Stifel	Buy
2024-02-23	Iniziato	Cantor Fitzgerald	Overweight
2023-09-22	Iniziato	Wedbush	Outperform
2023-03-23	Aggiornamento	H.C. Wainwright	Neutral → Buy
2023-03-21	Aggiornamento	Guggenheim	Neutral → Buy
2023-03-16	Aggiornamento	Oppenheimer	Perform → Outperform
2022-07-18	Ripresa	Oppenheimer	Perform
2022-04-04	Aggiornamento	Citigroup	Neutral → Buy
2022-03-25	Downgrade	H.C. Wainwright	Buy → Neutral
2022-03-22	Downgrade	Citigroup	Buy → Neutral
2022-03-22	Downgrade	Guggenheim	Buy → Neutral
2022-03-22	Downgrade	Oppenheimer	Outperform → Perform
2021-07-06	Aggiornamento	Citigroup	Neutral → Buy
2021-01-25	Downgrade	Citigroup	Buy → Neutral
2020-08-13	Iniziato	Robert W. Baird	Outperform
2020-08-06	Aggiornamento	Citigroup	Neutral → Buy
2020-08-03	Iniziato	H.C. Wainwright	Buy
2020-05-19	Iniziato	Citigroup	Neutral
2020-05-19	Iniziato	Guggenheim	Buy
2020-05-19	Iniziato	JP Morgan	Overweight
2020-05-19	Iniziato	Jefferies	Buy

Mostra tutto

Oric Pharmaceuticals Inc Borsa (ORIC) Ultime notizie

Oct 25, 2025

What technical models suggest about ORIC Pharmaceuticals Inc.’s comebackJuly 2025 Sector Moves & Weekly Market Pulse Updates - newser.com

Oct 25, 2025

Why ORIC Pharmaceuticals Inc. (4TZ) stock stays on top picksTrade Analysis Summary & Weekly Top Performers Watchlists - newser.com

Oct 25, 2025

Has ORIC Pharmaceuticals Inc. found a price floorJuly 2025 Setups & Technical Confirmation Trade Alerts - newser.com

Oct 25, 2025

Will ORIC Pharmaceuticals Inc. stock split again soonEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com

Oct 25, 2025

Relative strength of ORIC Pharmaceuticals Inc. in sector analysisWeekly Gains Summary & AI Forecast for Swing Trade Picks - newser.com

Oct 25, 2025

Sentiment analysis tools applied to ORIC Pharmaceuticals Inc.July 2025 Retail & Risk Controlled Stock Pick Alerts - newser.com

Oct 25, 2025

How to read the order book for ORIC Pharmaceuticals Inc.July 2025 Review & Real-Time Chart Breakout Alerts - newser.com

Oct 25, 2025

Can you recover from losses in ORIC Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Community Shared Stock Ideas - newser.com

Oct 25, 2025

Oct 24, 2025